Skip to content
10-Q

Quarterly Report

UROPLASTY INC

0001140361-14-030111

← back to feed
Filed
Jul 31, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Capex Q1 2014 · Jun 30, 2014 $52.74K
Capex Q1 2014 · Jun 30, 2013 $189.79K
Operating Cash Flow Q1 2014 · Jun 30, 2014 −$1.51M
Operating Cash Flow Q1 2014 · Jun 30, 2013 −$685.09K
Short Term Investments Q1 2014 · Jun 30, 2014 $400K
Short Term Investments Q1 2014 · Mar 31, 2014 $3.45M
Cash And Equivalents Q1 2014 · Jun 30, 2014 $10.22M
Cash And Equivalents Q1 2014 · Mar 31, 2014 $8.68M
Cash And Equivalents Q1 2014 · Jun 30, 2013 $4.49M
Cash And Equivalents Q1 2014 · Mar 31, 2013 $3.53M
Stockholders Equity Q1 2014 · Jun 30, 2014 $11.38M
Stockholders Equity Q1 2014 · Mar 31, 2014 $13.21M
Current Liabilities Q1 2014 · Jun 30, 2014 $3.5M
Current Liabilities Q1 2014 · Mar 31, 2014 $3.41M
Total Liabilities Q1 2014 · Jun 30, 2014 $4.24M
Total Liabilities Q1 2014 · Mar 31, 2014 $4.09M
Current Assets Q1 2014 · Jun 30, 2014 $14.38M
Current Assets Q1 2014 · Mar 31, 2014 $16.03M
Total Assets Q1 2014 · Jun 30, 2014 $15.62M
Total Assets Q1 2014 · Mar 31, 2014 $17.3M
Sga Expense Q1 2014 · Jun 30, 2014 $1.58M
Sga Expense Q1 2014 · Jun 30, 2013 $1.58M
Rd Expense Q1 2014 · Jun 30, 2014 $909.44K
Rd Expense Q1 2014 · Jun 30, 2013 $479.66K
Net Income Q1 2014 · Jun 30, 2014 −$2.19M
Net Income Q1 2014 · Jun 30, 2013 −$1.61M
Operating Income Q1 2014 · Jun 30, 2014 −$2.17M
Operating Income Q1 2014 · Jun 30, 2013 −$1.6M
Gross Profit Q1 2014 · Jun 30, 2014 $5.59M
Gross Profit Q1 2014 · Jun 30, 2013 $5.09M
Cost Of Revenue Q1 2014 · Jun 30, 2014 $791.31K
Cost Of Revenue Q1 2014 · Jun 30, 2013 $748.05K
Revenue Q1 2014 · Jun 30, 2014 $6.39M
Revenue Q1 2014 · Jun 30, 2013 $5.84M
Shares Outstanding Q1 2014 · May 30, 2014 22.01M sh